We are experiencing 4 week turn-around time in review of submissions and resubmissions. We recommend commencing this process concurrently with your ethics submission and allowing at least 8 weeks for registration to be completed from date of first submission. We currently do not have the capacity to expedite reviews.

Note also there are delays to review of updates. We appreciate your patience.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12613000792729
Ethics application status
Approved
Date submitted
11/07/2013
Date registered
16/07/2013
Date last updated
25/10/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
immune investigation in patients with chronic prostatitis
Scientific title
Differential expression of serum IgA,IgM, IgG,CD4 and CD8 between patients with chronic prostatitis and healthy controls
Secondary ID [1] 282809 0
Nil
Universal Trial Number (UTN)
U1111-1145-4774
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
chronic prostatitis 289584 0
Condition category
Condition code
Renal and Urogenital 289918 289918 0 0
Other renal and urogenital disorders

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
investigating the difference of serum marker including IgA, IgM,IgG,CD4 and CD8 between patients with chronic prostatitis and healthy population; participants are asked to give a blood sample on one occasion only immediately after their diagnosis of chronic prostatitis or their involving in the study as the healthy controls
Intervention code [1] 287493 0
Not applicable
Comparator / control treatment
serum IgA, IgM,IgG,CD4 and CD8 were investigated in healthy population
Control group
Active

Outcomes
Primary outcome [1] 289972 0
serum immune marker including serum IgA, IgM, IgG, CD4 and CD8 was assayed
Timepoint [1] 289972 0
immediately after the diagnosis
Secondary outcome [1] 303688 0
symptom score ( NIH-CPSI) was evaluated
Timepoint [1] 303688 0
immediately after the diagnosis

Eligibility
Key inclusion criteria
the history of prostate pain longer than 3 months;age between 18 and 45; normal urin routine and negative urine culture
Minimum age
18 Years
Maximum age
45 Years
Gender
Males
Can healthy volunteers participate?
No
Key exclusion criteria
prostatitis(I,II, IV); the pain not from chronic prostatitis but related to the other pelvic diseases

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 5181 0
China
State/province [1] 5181 0
shanghai

Funding & Sponsors
Funding source category [1] 287587 0
Hospital
Name [1] 287587 0
changhai hospital 1255 grant
Address [1] 287587 0
urology department, changhai hospital
changhai road 168#, shanghai, China, 200433
Country [1] 287587 0
China
Primary sponsor type
Individual
Name
Tie Zhou
Address
urology department, changhai hospital
changhai road 168#, shanghai, China, 200433
Country
China
Secondary sponsor category [1] 286334 0
None
Name [1] 286334 0
Address [1] 286334 0
Country [1] 286334 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 289560 0
changhai ethic comittee
Ethics committee address [1] 289560 0
changhai road 168#, shanghai, China, 200433
Ethics committee country [1] 289560 0
China
Date submitted for ethics approval [1] 289560 0
20/04/2013
Approval date [1] 289560 0
28/04/2013
Ethics approval number [1] 289560 0
CHEC2013-056

Summary
Brief summary
By comparing the serum immune marker between patients with chronic prostatitis and healthy controls to investigate the relationship of immune status to chronic prostatitis
Trial website
Trial related presentations / publications

Int Urol Nephrol. 2018 Mar;50(3):395-399.
doi: 10.1007/s11255-017-1763-z. Epub 2017 Dec 12.

Public notes

Contacts
Principal investigator
Name 41330 0
A/Prof Tie Zhou
Address 41330 0
urology department, changhai hospital,
changhai road 168#, shanghai, China,200433
Country 41330 0
China
Phone 41330 0
+862113918360523
Fax 41330 0
Email 41330 0
wenzhoutie80@yahoo.com
Contact person for public queries
Name 41331 0
A/Prof Zhou tie
Address 41331 0
urology department, changhai hospital,
changhai road 168#, shanghai, China,200433
Country 41331 0
China
Phone 41331 0
+862113918360523
Fax 41331 0
Email 41331 0
wenzhoutie80@yahoo.com
Contact person for scientific queries
Name 41332 0
A/Prof zhou tie
Address 41332 0
urology department, changhai hospital,
changhai road 168#, shanghai, China,200433
Country 41332 0
China
Phone 41332 0
+862113918360523
Fax 41332 0
Email 41332 0
wenzhoutie80@yahoo.com

No information has been provided regarding IPD availability
Summary results
Have study results been published in a peer-reviewed journal?
Other publications
Have study results been made publicly available in another format?
Results – basic reporting
Results – plain English summary